ArticleLeukemia2019

KRAS, NRAS, and BRAF mutations are highly enriched in trisomy 12 chronic lymphocytic leukemia and are associated with shorter treatment-free survival.

Elena Vendramini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.